Send to printer »

GEN News Highlights : Oct 30, 2006

Mentor and Genzyme to Partner on Hyaluronic Acid Dermal Fillers

Firms focused on future development and commercialization of facial aesthetics pipeline.

Genzyme will develop future hyaluronic acid (HA) dermal filler products according to a commercialization agreement with Mentor.

The first product launch under the agreement is scheduled to occur internationally in early 2007, with a worldwide launch of an additional product in late 2007.

Genzyme and Mentor will join resources to develop a longer-lasting HA dermal filler. With Genzyme's history in HA development and manufacturing, Mentor has created a partnership that will allow its facial aesthetics pipeline to expand significantly. All the products will be introduced into Mentor's current distribution network, maximizing the revenue opportunity.